Dendritic cell vaccination
Sponsors
Baylor Research Institute, Southern Cancer Center, University of Michigan Rogel Cancer Center, Quantum Immunologics, Inc., University Hospital, Antwerp
Conditions
Breast CancerMalignant Pleural MesotheliomaMelanomaMetastatic Breast CancerMetastatic Pancreatic CarcinomaNeoplasm Metastasis
Phase 1
Vaccination of Patients With Stage IV Melanoma With Dendritic Cells
CompletedNCT00125749
Start: 2005-07-31End: 2007-06-30Updated: 2017-06-12
A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer
NCT00715832
Start: 2008-05-31End: 2015-02-28Target: 25Updated: 2009-08-26
A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma
TerminatedNCT00843830
Start: 2006-10-31End: 2010-04-30Updated: 2015-12-08
Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer
NCT00879489
Start: 2008-05-31End: 2011-09-30Target: 24Updated: 2011-02-25
Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
RecruitingNCT05765084
Start: 2023-02-24End: 2027-10-01Target: 15Updated: 2026-06-05